Pliant Therapeutics Inc. (PLRX)
NASDAQ: PLRX
· Real-Time Price · USD
1.54
-0.03 (-2.22%)
At close: Aug 15, 2025, 3:59 PM
1.54
-0.32%
After-hours: Aug 15, 2025, 05:57 PM EDT
Pliant Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 86.82M | 91.94M | 71.19M | 79.62M | 80.39M | 114.3M | 63.23M | 57.68M | 54.95M | 102.53M | 33.69M | 44.62M | 25.07M | 32.55M | 51.66M | 45.23M | 35.19M | 50.82M |
Short-Term Investments | 176.05M | 213.71M | 284.54M | 324.9M | 356.22M | 368.09M | 431.01M | 465.93M | 500.21M | 474.79M | 297.5M | 315.62M | 138.53M | 145.74M | 148.93M | 175.81M | 208.79M | 213.28M |
Long-Term Investments | 1.48M | n/a | n/a | n/a | 1.48M | 1.48M | 1.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 391K | 1.91M | 1.92M | 1.91M | 437K | 392K | 392K | 392K | 672K | 644K | 394K | 397K | 913K | 835K | 838K | 831K | 630K | 451K |
Receivables | 1.53M | 1.68M | 2.3M | 2.22M | 2.8M | 2.31M | 3M | 2.12M | 4.02M | 4.76M | 1.98M | 2.32M | 5.39M | 1.33M | 2M | 1.69M | 1.91M | 2.26M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.93M | 6.29M | 5.74M | n/a | 3.2M | 4.33M | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.04M | 57K | 163K | 685K | 741K | 611K | 1.27M | -7.26M | 229K | 418K | 2.29M | 207K | 212K | n/a | 1.44M | n/a | n/a | n/a |
Total Current Assets | 267.44M | 311.19M | 362.26M | 410.03M | 447.55M | 489.9M | 505.5M | 534.34M | 565.7M | 588.23M | 340.31M | 365.96M | 173.53M | 185.36M | 209.44M | 228.58M | 250.72M | 270.54M |
Property-Plant & Equipment | 30.51M | 31.67M | 32.77M | 33.73M | 34.26M | 29.83M | 4.78M | 5.74M | 8.52M | 9.01M | 9.91M | 10.82M | 10.18M | 10.82M | 10.94M | 4.71M | 4.37M | 4.27M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 32.38M | 33.58M | 34.69M | 35.63M | 36.18M | 31.71M | 6.65M | 6.13M | 9.19M | 9.65M | 10.3M | 11.21M | 11.09M | 11.66M | 11.77M | 5.54M | 5M | 4.72M |
Total Assets | 299.82M | 344.77M | 396.95M | 445.67M | 483.73M | 521.61M | 512.15M | 540.46M | 574.89M | 597.88M | 350.61M | 377.18M | 184.62M | 197.02M | 221.22M | 234.12M | 255.72M | 275.25M |
Account Payables | 1.38M | 5.62M | 5.96M | 6.89M | 3.25M | 7.33M | 4.53M | 3.36M | 2.31M | 1.42M | 1.58M | 3.21M | 3.12M | 4.68M | 2.97M | 2.6M | 2.76M | 2.89M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -773K | n/a | n/a | n/a | n/a | n/a | n/a | -2.04M | n/a | 1.87M | n/a | n/a | n/a |
Short-Term Debt | 1.23M | n/a | n/a | 322K | 98K | 773K | 1.32M | 2.06M | 2.23M | 2.38M | 2.46M | 2.65M | n/a | 2M | 1.87M | n/a | n/a | n/a |
Other Current Liabilities | 11.75M | 5.39M | 11.15M | -322K | 20.87M | n/a | 12.31M | 13.23M | 17M | 13.53M | 10.22M | 12.95M | n/a | 6.99M | 4.91M | 138K | 120K | 103K |
Total Current Liabilities | 20.59M | 28.2M | 33.22M | 39.95M | 30.92M | 30.39M | 28.52M | 27.39M | 29.52M | 23.15M | 23.91M | 26.16M | 22.55M | 18.31M | 16.83M | 12.93M | 10.93M | 10.25M |
Long-Term Debt | 28.79M | 30.28M | 30.21M | 30.14M | 30.07M | 30M | 10.05M | 10.02M | 9.99M | 9.96M | 9.93M | 9.9M | 9.87M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 30.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 756K | 561K | 835K |
Total Long-Term Liabilities | 59.15M | 59.4M | 59.65M | 59.89M | 60.13M | 53.88M | 10.05M | 10.02M | 12.31M | 12.81M | 13.36M | 14.03M | 14.28M | 4.92M | 5.33M | 756K | 804K | 835K |
Total Liabilities | 79.74M | 87.61M | 92.87M | 99.84M | 91.05M | 84.27M | 38.58M | 37.42M | 41.83M | 35.96M | 37.27M | 40.19M | 36.83M | 23.23M | 22.16M | 13.68M | 11.74M | 11.09M |
Total Debt | 30.02M | 60.17M | 60.19M | 60.21M | 60.23M | 54.66M | 11.37M | 12.08M | 14.54M | 15.19M | 15.81M | 16.68M | 16.32M | 6.92M | 7.19M | n/a | 243K | 263K |
Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -809.52M | -766.22M | -710.05M | -660.32M | -602.56M | -546.7M | -499.75M | -458.64M | -417.15M | -375.96M | -338.41M | -303.35M | -272.74M | -243.19M | -215.09M | -190.56M | -163.51M | -140.68M |
Comprehensive Income | -1K | 159K | 321K | 848K | -617K | -489K | 345K | -1.91M | -2.24M | -1.33M | -1.96M | -2.45M | -1.26M | -950K | -201K | -40K | -30K | -18K |
Shareholders Equity | 220.08M | 257.16M | 304.08M | 345.82M | 392.68M | 437.33M | 473.58M | 503.05M | 533.07M | 561.92M | 313.34M | 336.99M | 147.79M | 173.79M | 199.06M | 220.44M | 243.98M | 264.17M |
Total Investments | 177.53M | 213.71M | 284.54M | 324.9M | 357.7M | 369.57M | 432.49M | 465.93M | 500.21M | 474.79M | 297.5M | 315.62M | 138.53M | 145.74M | 148.93M | 175.81M | 208.79M | 213.28M |